Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Tillotts Pharma
Tillotts Pharma
Activities:
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Tillotts launches Octasa tablets in Canada
The introduction of these delayed-release tablets is expected to increase the options for UC patients managed with mesalazine
Finance
Tillotts Pharma launches affiliate in Italy
The subsidiary will be led by Fabrizio Savoldi as MD
Research & Development
Tillotts signs IBD research agreement
Discovery efforts with LabGenius to identify and develop new drug candidates for the treatment of inflammatory bowel diseases
Recruitment
Tillotts Pharma and Zeria appoint new Global Head of Innovation
Manufacturing
Recipharm establishes long-term supply agreement with Tillotts Pharma
Swedish CDMO will handle technology transfer and commercial manufacturing of gastro-enterology products
Finance
Tillotts Pharma sets up affiliates in Czech Republic and UK
To focus on Asacol and Octasa brands
Subscribe now